Portfolio

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), is a bill before the House that is intended to make prescription drugs more affordable for those in the Medicare program. The bill also seeks to maintain Medicare’s future viability.

In effect, the power of the digital fingerprinting and related DNA sampling now in use in law enforcement can be put to work for foodborne illness outbreaks.

It’s become increasingly clear that the life science sector faces acute disruption as a result of this period of uncertainty, whether or not a satisfactory Brexit deal is ultimately reached.

This article is brought to you by Cambridge Consultants, a global product development and technology consultancy firm that helps companies […]

Oklahoma was the first state to file suit against opioid manufacturers. The success of their legal strategy will have a significant impact on the opioid–and pharmaceutical–industry going forward.

Although asthma is a common chronic disease, there is currently no cure for it. Currently, physicians use a variety of means to reduce inflammation and keep it at bay. The extent of their success depends upon environmental factors, patient compliance and the “fit” of the treatment.